Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,512 | 17,708 | N/A | N/A | N/A |
| Marketable Securities | 64,682 | N/A | N/A | N/A | N/A |
| TOTAL | $111,778 | $18,904 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 149 | 311 | N/A | N/A | N/A |
| Other Non-Current Assets | 252 | 255 | 0 | 0 | 0 |
| TOTAL | $400 | $566 | $N/A | $N/A | $N/A |
| Total Assets | $112,179 | $19,470 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,746 | 1,504 | 0 | 0 | 0 |
| Other current liabilities | 7,597 | N/A | N/A | N/A | N/A |
| TOTAL | $12,964 | $4,032 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,622 | 2,446 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 22,762 | 5,836 | 0 | 0 | 0 |
| TOTAL | $33,303 | $17,998 | $N/A | $N/A | $N/A |
| Total Liabilities | $46,267 | $22,030 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 17 | 3 | N/A | N/A | N/A |
| Retained earnings | -118,183 | -74,540 | N/A | N/A | N/A |
| Other shareholders' equity | -21 | -185 | 0 | 0 | 0 |
| TOTAL | $65,912 | $-2,560 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $112,179 | $19,470 | $0 | $0 | $0 |